HR 3433, the "Give Kids a Chance Act of 2024," requires pharmaceutical companies developing certain cancer drugs to conduct pediatric studies if the drugs target molecular pathways relevant to childhood cancers. It directly affects drug manufacturers submitting new applications for cancer treatments, particularly those combining previously approved adult cancer drugs or containing a single new active ingredient. The bill amends FDA regulations to mandate these pediatric investigations only when specific conditions are met, such as when a drug's molecular target is relevant to pediatric cancer growth. The FDA must issue implementing guidance within 12 months, and reports to Congress will track implementation and effectiveness starting 2 years after enactment.
This bill prohibits hospitals and transplant centers from denying organ transplants or related services to people with disabilities solely because of their disability. It requires covered entities to make reasonable modifications to policies (like considering a patient's support network for post-transplant care) and provide auxiliary aids (such as communication services or accessible health information). The law specifically prevents discrimination based on disability during evaluation, listing, and treatment, while clarifying that medical decisions must be based on individualized assessments - not disability alone. It applies to all organ transplant processes and allows individuals to file complaints with the Department of Health and Human Services or sue for violations.
HJRES 136 is a resolution seeking to block an Environmental Protection Agency (EPA) rule that would have set new emissions standards for light and medium-duty vehicles sold in 2027 and later model years. The EPA rule, published in April 2024, aimed to require vehicle manufacturers to meet stricter pollution limits for these vehicles. If passed, this resolution would cancel the rule, preventing the EPA from enforcing the new standards. It uses a congressional process that allows Congress to reject agency rules with a simple majority vote.
S 3187, the Southern Border Transparency Act of 2023, requires U.S. Customs and Border Protection (CBP) and the Department of Homeland Security (DHS) to publish detailed immigration data monthly and quarterly. It mandates CBP to post on its website the number of people granted parole at ports of entry, broken down by nationality, age group (like minors or families), and location. DHS must submit quarterly reports to Congress and post them online, detailing apprehensions, processing outcomes (such as parole, removal, or asylum screenings), and demographic breakdowns along the southern border. The bill also updates annual reporting requirements to track parolees' status, including employment authorization and whether their parole ended or was extended. These requirements directly affect CBP and DHS operations, aiming to increase public and congressional transparency about border processing.
HR 8292, the Taxpayer Data Protection Act, increases penalties for unauthorized disclosures of taxpayer information under the Internal Revenue Code. It raises fines from $5,000 to $250,000 per violation and increases potential jail time from 5 to 10 years for those who disclose such data. The bill also specifies that if a single disclosure affects multiple taxpayers, each affected person counts as a separate violation, potentially increasing penalties. This law directly affects IRS employees and government workers handling taxpayer data, applying to disclosures made after the bill's enactment.
HR 7208 reauthorizes three existing programs under the Public Health Service Act through 2029, extending current funding periods that previously expired after 2024. It updates the authorization periods for (1) traumatic brain injury prevention efforts, (2) state grants for TBI-related projects, and (3) state grants supporting protection and advocacy services for people with disabilities. The bill directly affects states receiving federal grants under these programs by allowing continued funding for services like TBI care coordination, community support, and legal advocacy. No new policies or funding levels are created - only the timeline for existing programs is extended. This is a procedural reauthorization, not a policy change.
This bill modifies Medicaid and CHIP rules to let eligible out-of-state healthcare providers enroll without extra state screening. It applies to providers already in Medicare or their home state program, with low fraud risk, serving children under 21 with complex medical conditions. Providers would receive 5 years of enrollment under this streamlined process, eliminating state-level barriers. The change directly affects children seeking specialized care across state lines and the providers who serve them.
The Fairness for Servicemembers and their Families Act of 2024 requires the Department of Veterans Affairs to review the automatic maximum coverage amount for Servicemembers’ Group Life Insurance (SGLI) and Veterans’ Group Life Insurance (VGLI) every three years, starting January 1, 2024. The review compares the current coverage amount to a new inflation-adjusted figure calculated as $400,000 multiplied by the cumulative increase in the Consumer Price Index (CPI) since 2005. The results of each review must be submitted to Congress. This provision directly affects active-duty service members and veterans enrolled in SGLI or VGLI by establishing a process to potentially increase their automatic coverage to keep pace with inflation.
HR 1425, the "No WHO Pandemic Preparedness Treaty Without Senate Approval Act," requires the U.S. Senate to approve any World Health Organization (WHO) pandemic preparedness treaty through a two-thirds vote. The bill deems any convention, agreement, or international instrument on pandemic prevention drafted by the WHO’s International Negotiating Body (INB) as a treaty subject to Senate ratification, rather than allowing it to take effect as an executive agreement. This directly affects U.S. foreign policy implementation regarding WHO agreements, ensuring Congress has a formal role in approving such binding international commitments. The bill stems from congressional concerns about WHO’s pandemic response and public skepticism toward the organization, as outlined in its findings.
This bill adds the Secretary of Agriculture to the Committee on Foreign Investment in the U.S. (CFIUS) for transactions involving agricultural land, biotechnology, or agriculture-related infrastructure (like transportation, storage, or processing). It requires the Secretary to notify CFIUS about transactions where a foreign person from China, North Korea, Russia, or Iran acquires U.S. agricultural assets, as defined by existing law. CFIUS then decides whether to review such transactions or take other action. The provisions apply only to transactions involving those four countries and sunset once they are removed from the official list of "foreign adversaries" in federal regulations.
HR 7159, the Pacific Partnership Act, mandates the U.S. government to develop a comprehensive strategy for engagement with Pacific Island nations. It requires the President, by January 1, 2026, and every four years thereafter, to submit a detailed strategy to Congress outlining U.S. diplomatic, defense, and economic goals in the region, including assessments of threats like natural disasters, illegal fishing, and foreign military activity. The strategy must detail plans to address these threats, coordinate with Pacific Island governments and regional organizations like the Pacific Islands Forum, and outline required resources and staffing. This bill directly affects U.S. foreign policy operations and shapes how the federal government engages with Pacific Island nations on shared security, economic, and environmental priorities.
HRES 1056 is a non-binding House resolution recognizing recent trilateral cooperation among the United States, Japan, and South Korea. It formally acknowledges specific collaborative efforts, including resumed summitry, joint military exercises, shared missile warning systems, economic partnerships, and coordinated responses to regional challenges like North Korea and crises in Sudan and Israel. The resolution does not create new policies or funding but expresses congressional support for strengthening this alliance framework. It highlights the importance of continued cooperation across diplomatic, security, and economic domains to promote stability in the Western Pacific. The resolution was introduced by multiple House members and referred to the Foreign Affairs Committee.
